Diagnostic tests often fail to lead to changes in patient outcomes.
暂无分享,去创建一个
John P A Ioannidis | Despina G Contopoulos-Ioannidis | George C M Siontis | J. Ioannidis | D. Contopoulos-Ioannidis | G. Siontis | Konstantinos C. Siontis | Konstantinos C Siontis
[1] P. Gøtzsche,et al. Screening for breast cancer with mammography. , 2013, The Cochrane database of systematic reviews.
[2] Mark P Purdue,et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. , 2012, The New England journal of medicine.
[3] John P. A. Ioannidis,et al. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. , 2012, JAMA.
[4] Anne Eisinga,et al. A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare. , 2012, Journal of clinical epidemiology.
[5] P. Bossuyt,et al. Assessing the value of diagnostic tests: a framework for designing and evaluating trials , 2012, BMJ : British Medical Journal.
[6] John P A Ioannidis,et al. Reversals of established medical practices: evidence to abandon ship. , 2012, JAMA.
[7] Vinay Prasad,et al. The frequency of medical reversal. , 2011, Archives of internal medicine.
[8] J. Thigpen. Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial , 2011 .
[9] A. Rosman,et al. Effect of Verification Bias on the Sensitivity of Fecal Occult Blood Testing: a Meta-Analysis , 2010, Journal of General Internal Medicine.
[10] Armando Santoro,et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. , 2009, American journal of respiratory and critical care medicine.
[11] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[12] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[13] M. Lauer,et al. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. , 2009, Journal of cardiovascular computed tomography.
[14] E. Barrett,et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.
[15] J. Lijmer,et al. Various randomized designs can be used to evaluate medical tests. , 2009, Journal of clinical epidemiology.
[16] Rongwei Fu,et al. Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.
[17] J. Sch. GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies , 2008, BMJ : British Medical Journal.
[18] Gordon H Guyatt,et al. GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies , 2008, BMJ : British Medical Journal.
[19] Iztok Hozo,et al. Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. , 2008, Archives of internal medicine.
[20] J. Neilson,et al. Routine ultrasound in late pregnancy (after 24 weeks' gestation). , 2008, The Cochrane database of systematic reviews.
[21] Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.
[22] D. Ramaekers,et al. The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed. , 2007, Journal of clinical epidemiology.
[23] J. Neilson,et al. WITHDRAWN: Routine ultrasound in late pregnancy (after 24 weeks' gestation). , 2007, The Cochrane database of systematic reviews.
[24] G. Leng,et al. Screening for abdominal aortic aneurysm. , 2007, The Cochrane database of systematic reviews.
[25] T. Wilt,et al. Screening for prostate cancer. , 2013, The Cochrane database of systematic reviews.
[26] C. Mancuso,et al. Randomized controlled clinical trial of point-of-care, limited ultrasonography for trauma in the emergency department: the first sonography outcomes assessment program trial. , 2006, Annals of emergency medicine.
[27] D. Grobbee,et al. Distraction from randomization in diagnostic research. , 2006, Annals of epidemiology.
[28] Sarah Lord,et al. When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials? , 2006, Annals of Internal Medicine.
[29] T. Wilt,et al. Screening of prostate cancer. Is it needed? Russian experience , 2006 .
[30] David J Samson,et al. Challenges in Systematic Reviews of Diagnostic Technologies , 2005, Annals of Internal Medicine.
[31] E. Chan. Promoting an ethical approach to unproven screening imaging tests. , 2005, Journal of the American College of Radiology : JACR.
[32] P. Rothwell,et al. External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.
[33] Konrad Jamrozik,et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm , 2004, BMJ : British Medical Journal.
[34] P. Bossuyt,et al. The diagnostic odds ratio: a single indicator of test performance. , 2003, Journal of clinical epidemiology.
[35] G. Cable,et al. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. , 2003, The Journal of the American Board of Family Practice.
[36] A R Feinstein,et al. Misguided efforts and future challenges for research on “diagnostic tests” , 2002, Journal of epidemiology and community health.
[37] D. Sackett,et al. The architecture of diagnostic research , 2002, BMJ : British Medical Journal.
[38] Gabriel P Krestin,et al. Study design for concurrent development, assessment, and implementation of new diagnostic imaging technology. , 2002, Radiology.
[39] K. Maršál,et al. Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial , 2001, The Lancet.
[40] S. Chinn. A simple method for converting an odds ratio to effect size for use in meta-analysis. , 2000, Statistics in medicine.
[41] P. Bossuyt,et al. Randomised comparisons of medical tests: sometimes invalid, not always efficient , 2000, The Lancet.
[42] T. Merigan,et al. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy , 2000 .
[43] P. Glasziou,et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. , 2000, The Cochrane database of systematic reviews.
[44] J. Neilson,et al. Routine ultrasound in late pregnancy (after 24 weeks gestation). , 2000, The Cochrane database of systematic reviews.
[45] J. Neilson,et al. Ultrasound for fetal assessment in early pregnancy. , 2000, The Cochrane database of systematic reviews.
[46] J. Lindholt,et al. The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. , 1999, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[47] P. Glasziou,et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. , 1998, BMJ.
[48] J. Ioannidis,et al. Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.